Date of Publication: January 2013
The aesthetic industry remains strong, driven by aging populations throughout the world, as well as increased awareness of advanced procedures and improving technology that provides more significant benefits with reduced risk and downtime. Dynamic Asian economies coupled with a growing middle class will also support industry growth, although ongoing financial challenges in Europe will constrain greater global gains.
In 2012, total sales of aesthetic products covered in this report exceeded $5.7 billion, up from $4.9 billion in 2011 as sales from the major manufacturers rebounded strongly. Through 2017, they will expand by 11.6% per year to $9.9 billion. This is lower than the compound annual growth of 13.5% predicted in GAM X, released in early 2012, and will be caused by acceleration in the large energy-based devices segment mitigated by slower growth in the emerging products, physician-dispensed topicals, neuromodulators, dermal fillers and chemical peels segments.
This report provides detailed insight on:
- Extension of sales forecasts from 2011 to 2016 in GAM X to 2012 to 2017;
- comparison of current forecasts to GAM X forecasts and discussion of changes;
- major expansion of Body Shaping and Skin Tightening systems in Section 4; Physician-Dispensed Topicals in Section 10; and Emerging Products in Section 11;
- analysis of political, economic and other factors impacting the aesthetic market, particularly in the U.S. and Europe
Your Price: $9,950 Buy Now